591 related articles for article (PubMed ID: 6241706)
21. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
22. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers.
Star WM; Marijnissen HP; van den Berg-Blok AE; Versteeg JA; Franken KA; Reinhold HS
Cancer Res; 1986 May; 46(5):2532-40. PubMed ID: 3697992
[TBL] [Abstract][Full Text] [Related]
23. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic effect of hematoporphyrin derivative as a function of optical spectrum and incident energy density.
Kinsey JH; Cortese DA; Moses HL; Ryan RJ; Branum EL
Cancer Res; 1981 Dec; 41(12 Pt 1):5020-6. PubMed ID: 7307004
[TBL] [Abstract][Full Text] [Related]
25. The effect of tumor localizing porphyrins on the conversion of fibrinogen to fibrin.
Musser DA; Wagner JM; Weber FJ; Datta-Gupta N
Res Commun Chem Pathol Pharmacol; 1979 Nov; 26(2):357-82. PubMed ID: 523777
[TBL] [Abstract][Full Text] [Related]
26. Effect of 514.5-nm argon ion laser radiation on hematoporphyrin derivative-treated bladder tumor cells in vitro and in vivo.
Bellnier DA; Prout GR; Lin CW
J Natl Cancer Inst; 1985 Mar; 74(3):617-25. PubMed ID: 3856065
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo.
Hua Z; Gibson SL; Foster TH; Hilf R
Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481
[TBL] [Abstract][Full Text] [Related]
28. Treatment of murine intraperitoneal ovarian ascitic tumor with hematoporphyrin derivative and laser light.
Tochner Z; Mitchell JB; Harrington FS; Smith P; Russo DT; Russo A
Cancer Res; 1985 Jul; 45(7):2983-7. PubMed ID: 4005837
[TBL] [Abstract][Full Text] [Related]
29. Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas.
Gibson SL; Murant RS; Hilf R
Cancer Res; 1988 Jun; 48(12):3360-6. PubMed ID: 2836053
[TBL] [Abstract][Full Text] [Related]
30. Picosecond fluorescence of R3230AC mammary carcinoma mitochondria after treatment with hematoporphyrin derivative and Photofrin II in vivo.
Hanzlik CA; Knox RS; Gibson SL; Hilf R
Photochem Photobiol; 1989 Jul; 50(1):45-53. PubMed ID: 2527374
[TBL] [Abstract][Full Text] [Related]
31. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy.
Nelson JS; Roberts WG; Berns MW
Cancer Res; 1987 Sep; 47(17):4681-5. PubMed ID: 2957047
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue.
Gomer CJ; Jester JV; Razum NJ; Szirth BC; Murphree AL
Cancer Res; 1985 Aug; 45(8):3718-25. PubMed ID: 4016749
[TBL] [Abstract][Full Text] [Related]
33. Transport and binding of hematoporphyrin derivative and related porphyrins by murine leukemia L1210 cells.
Kessel D
Cancer Res; 1981 Apr; 41(4):1318-23. PubMed ID: 7214321
[TBL] [Abstract][Full Text] [Related]
34. [Basic study for cancer therapy with porphyrin derivatives and pheophorbide derivatives].
Hayashi H; Nakajima S; Samejima N
Hokkaido Igaku Zasshi; 1985 May; 60(3):391-403. PubMed ID: 4018713
[TBL] [Abstract][Full Text] [Related]
35. Cellular binding of hematoporphyrin derivative (HpD) in human bladder cancer cell line: KK-47.
Hisazumi H; Miyoshi N; Ueki O; Nakajima K
Prog Clin Biol Res; 1984; 170():443-57. PubMed ID: 6241690
[TBL] [Abstract][Full Text] [Related]
36. Photosensitization of mitochondrial cytochrome c oxidase by hematoporphyrin derivative and related porphyrins in vitro and in vivo.
Gibson SL; Hilf R
Cancer Res; 1983 Sep; 43(9):4191-7. PubMed ID: 6307505
[TBL] [Abstract][Full Text] [Related]
37. Comparison of photosensitizers in saline and liposomes for tumor photodynamic therapy and skin phototoxicity.
Davis RK; Straight R; Kereszti Z
Laryngoscope; 1990 Jul; 100(7):682-6. PubMed ID: 2362527
[TBL] [Abstract][Full Text] [Related]
38. [Effect of ascorbate on the permeation and photosensitizing activity of hematoporphyrin derivative (HPD) in tumor].
Chen Y; Li C; Liu Y
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):350-2. PubMed ID: 10920914
[TBL] [Abstract][Full Text] [Related]
39. Effects of photosensitizer (hematoporphyrin derivative-HPD) and light dose on vascular targets in the albino mouse ear.
Davis RK; Davis K; Straight RC; Waner M
Laryngoscope; 1988 Jan; 98(1):1-4. PubMed ID: 3336250
[TBL] [Abstract][Full Text] [Related]
40. Phototoxicity of brain tissue in hematoporphyrin derivative treated mice.
Rounds DE; Doiron DR; Jacques DB; Shelden CH; Olson RS
Prog Clin Biol Res; 1984; 170():613-28. PubMed ID: 6241701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
